Aktienkurs
346.60
Täglich Wechseln
5.40 1.58%
Monatlich
20.14%
Jährlich
-18.62%
Q2 Prognose
324.96




Stock Veränderung Datum
Akebia Therapeutics USD 13M 2.61M 2026-03
Avita Medical AUD 6.93M 614K 2025-12
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Moderna USD 146M 7M 2026-03
Organon & Co USD 1.37B 33M 2026-03
Revvity USD 387.5M 8.01M 2026-03
Tilray USD 282.79M 11.9M 2025-06
Viatris USD 3.93B 72.2M 2026-03
Xeris Pharmaceuticals USD 74.23M 5.56M 2026-03
Zealand Pharma A/S 10.7M 9.9M 2024-12